Novel Laboratories · Recalled
Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning
The packaging for the prescription drug is not child-resistant as required by the Poison Prevention Packaging Act, posing a risk of poisoning if swallowed by children.
- Units
- About 5,700 boxes of 30 blister packs
- Reports
- —
- Injuries
- —
- Deaths
- 0
- Price
- $800
- Remedy
- Refund
Reports, injuries, deaths and price are read out of the notice’s wording by rules, so they can miss unusual phrasing. The official notice is the record.
Affected
This recall involves 1.75 mg and 3.5 mg Zolpidem Tartrate sublingual (rapid dissolve) tablets from Novel Laboratories. The prescription medication is a sleep drug. The packaging for the 1.75 mg tablets has lot number M16140A, 1.75 mg and national drug code (NDC) 43386-762-30. The packaging for the 3.5 mg tablets has lot number M16144A, 3.5mg and national drug code (NDC) 43386-761-30. The Zolpidem Tartrate is packaged as a single tablet in a peel-and-push blister pack inside an outer open-ended pouch with 30 pouches per box. The lot number and an expiration date of 02/2018 are printed on the bottom left of the pouches. The NDC is printed on the top left corner of the boxes. "Gavis" is printed in blue on the center of the white boxes and pouches.
The file
- Sold at
- Clinics and pharmacies nationwide, including CVS, Costco, Walgreens, Kroger, and Wegmans from March 2016 through May 2016 for about $800 per box of 30 tablets.
- Product type
- Tablet or Capsule Drugs
- Made in
- United States
- Recalled by
- Gavis Pharmaceuticals, of Somerset, N.J., Novel Laboratories, of Somerset, N.J.
Incident log
None reported
What the notice says to do
Consumers should immediately stop using the recalled tablets and contact Novel Laboratories for instructions to receive a full refund.
Novel Laboratories toll-free at (866) 403-7592 from 9 a.m. to 5 p.m. ET Monday through Friday or online at www.novellabs.net and click on "Important Zolpidem Information" for more information.
Recall notice published by the U.S. Consumer Product Safety Commission. This site is independent: always confirm on the official notice before acting.
